Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Publishing timestamp: 2024-07-26 11:03:23
Summary
Bristol Myers Squibb reported strong second-quarter earnings and revenue, raised full-year guidance, and plans to cut costs by $1.5 billion by 2025. Revenue growth driven by blockbuster drug Eliquis and other key treatments. Shares rose nearly 8% on the news.
Sentiment: POSITIVE
Keywords: breaking news, business, breaking news: business, bristol-myers squibb co, business news, biotechnology, biotech and pharmaceuticals, health care industry, joe biden, earnings, pfizer inc, pharmaceuticals,
Source: https://www.cnbc.com/2024/07/26/bristol-myers-squibb-bmy-earnings-q2-2024.html